Wells Fargo lowered the firm’s price target on Corebridge (CRBG) to $37 from $43 and keeps an Overweight rating on the shares. Into quarterly results for the insurance space, the firm says the focus should be on pricing, loss trend, and reserves for P&C companies, organic and margin for brokers, and sales/capital/guidance for life companies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge price target lowered to $33 from $35 at UBS
- Corebridge price target lowered to $35 from $39 at Barclays
- Corebridge price target lowered to $39 from $40 at BofA
- Corebridge Finalizes Multi-Stage Variable Annuity Reinsurance Deal
- Corebridge closes on individual retirement variable annuity transaction
